Viva Biotech Holdings (hkse:01873) Share Price

Company Profile

Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHN
T: +86 2160893288
https://www.vivabiotech.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,085

Recommended

We’re no longer certain that software firms will outperform over the next decade, but positive outcomes remain possible for names like Salesforce.

Dan Romanoff, CPA | 09 March 2026

We believe AI weakens the competitive advantage of these companies.

Roy Van Keulen | 09 March 2026

Tech saw solid earnings, but there are more questions around which companies will benefit from AI, and which will be hurt.

Rachel Schlueter | 06 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,708.90	131.60	-1.49%
CAC 40	7,993.49	52.31	-0.65%
DAX 40	23,591.03	224.72	-0.94%
Dow JONES (US)	47,501.55	453.19	-0.95%
FTSE 100	10,284.75	129.19	-1.24%
HKSE	25,028.52	728.77	-2.83%
NASDAQ	22,387.68	361.31	-1.59%
Nikkei 225	51,624.23	3,996.61	-7.19%
NZX 50 Index	13,099.55	518.34	-3.81%
S&P 500	6,740.02	90.69	-1.33%
S&P/ASX 200	8,483.90	118.40	-1.38%
SSE Composite Index	4,071.19	53.00	-1.29%